Predicting Outcomes After Lumbar Fusion for Degenerative Disease (FUSE-ML)
Development and External Validation of an International, Multicenter Machine Learning Algorithm for Prediction of Outcome After Lumbar Spinal Fusion for Degenerative Disease: The FUSE-ML Study
Sponsor: Bergman Clinics
Listed as NCT05161130, this observational or N/A phase trial focuses on Disk Herniated Lumbar and Low Back Pain and remains completed. Sponsored by Bergman Clinics, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Sep 2024 — Apr 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2022 — Jul 2024 [monthly]
Completed
-
Jan 2022 — Feb 2022 [monthly]
Completed
First recorded
Jan 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bergman Clinics
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .